TSHA
Taysha Gene Therapies Inc.
Company Overview
| Mkt Cap | $1.36B | Price | $4.96 |
| Volume | 2.68M | Change | +1.02% |
| P/E Ratio | -15.2 | Open | $4.91 |
| Revenue | $8.3M | Prev Close | $4.91 |
| Net Income | $-89.3M | 52W Range | $1.05 - $5.51 |
| Div Yield | N/A | Target | $9.77 |
| Overall | 55 | Value | 60 |
| Quality | 42 | Technical | 63 |
No chart data available
Stock Overview
Updated DailyTaysha Gene Therapies Inc. (TSHA) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $4.96 with a market capitalization of $1.36 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows TSHA with a volume of 2.68 million shares. The stock opened down 0.00% from yesterday's close of $4.91. Current analyst estimates project earnings of $-0.35 per share for this year, with next year targeting $-0.4.
TSHA demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for TSHA include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 97.0%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 01:45 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TSHA | $4.96 | +1.0% | 2.68M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Taysha Gene Therapies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW